Introduction to Biologic and Biosimilar Product Development and Analysis

The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction...

Full description

Bibliographic Details
Main Author: Nagel, Karen M. (Author, http://id.loc.gov/vocabulary/relators/aut)
Corporate Author: SpringerLink (Online service)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2018.
Edition:1st ed. 2018.
Series:AAPS Introductions in the Pharmaceutical Sciences,
Subjects:
Online Access:Full Text via HEAL-Link
LEADER 02473nam a2200493 4500
001 978-3-319-98428-5
003 DE-He213
005 20190619151412.0
007 cr nn 008mamaa
008 180927s2018 gw | s |||| 0|eng d
020 |a 9783319984285  |9 978-3-319-98428-5 
024 7 |a 10.1007/978-3-319-98428-5  |2 doi 
040 |d GrThAP 
050 4 |a RS380 
050 4 |a RS190-210 
072 7 |a TDCW  |2 bicssc 
072 7 |a MED072000  |2 bisacsh 
072 7 |a TDC  |2 thema 
082 0 4 |a 615.19  |2 23 
100 1 |a Nagel, Karen M.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Introduction to Biologic and Biosimilar Product Development and Analysis  |h [electronic resource] /  |c by Karen M. Nagel. 
250 |a 1st ed. 2018. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2018. 
300 |a XI, 109 p. 4 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a AAPS Introductions in the Pharmaceutical Sciences,  |x 2522-834X 
505 0 |a Recombinant DNA Technology -- Therapeutic Proteins -- Therapeutic Antibodies -- Analysis and Regulation of Biologics including Biosimilars. 
520 |a The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies. 
650 0 |a Pharmaceutical technology. 
650 0 |a Pharmacy. 
650 1 4 |a Pharmaceutical Sciences/Technology.  |0 http://scigraph.springernature.com/things/product-market-codes/B21010 
650 2 4 |a Pharmacy.  |0 http://scigraph.springernature.com/things/product-market-codes/F00008 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319984278 
776 0 8 |i Printed edition:  |z 9783319984292 
776 0 8 |i Printed edition:  |z 9783030074920 
830 0 |a AAPS Introductions in the Pharmaceutical Sciences,  |x 2522-834X 
856 4 0 |u https://doi.org/10.1007/978-3-319-98428-5  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)